IP Patent News

24/7 Technology, Internet, Bio Patent and Intellectual Property News & Information Service

Endologix second-quarter total revenue increases 19% to $15.7 million

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2010.

Tagged as: , , ,

Comments are closed.